Prkdc participates in mitochondrial genome maintenance and prevents adriamycin-induced nephropathy in mice

Natalia Papeta, Zongyu Zheng, Eric A. Schon, Sonja Brosel, Mehmet M. Altintas, Samih H. Nasr, Jochen Reiser, Vivette D. D'Agati, Ali G. Gharavi

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Adriamycin (ADR) is a commonly used chemotherapeutic agent that also produces significant tissue damage. Mutations to mitochondrial DNA (mtDNA) and reductions in mtDNA copy number have been identified as contributors to ADR-induced injury. ADR nephropathy only occurs among specific mouse inbred strains, and this selective susceptibility to kidney injury maps as a recessive trait to chromosome 16A1-B1. Here, we found that sensitivity to ADR nephropathy in mice was produced by a mutation in the Prkdc gene, which encodes a critical nuclear DNA double-stranded break repair protein. This finding was confirmed in mice with independent Prkdc mutations. Overexpression of Prkdc in cultured mouse podocytes significantly improved cell survival after ADR treatment. While Prkdc protein was not detected in mitochondria, mice with Prkdc mutations showed marked mtDNA depletion in renal tissue upon ADR treatment. To determine whether Prkdc participates in mtDNA regulation, we tested its genetic interaction with Mpv17, which encodes a mitochondrial protein mutated in human mtDNA depletion syndromes (MDDSs). While single mutant mice were asymptomatic, Prkdc/Mpv17 double-mutant mice developed mtDNA depletion and recapitulated many MDDS and ADR injury phenotypes. These findings implicate mtDNA damage in the development of ADR toxicity and identify Prkdc as a MDDS modifier gene and a component of the mitochondrial genome maintenance pathway.

Original languageEnglish (US)
Pages (from-to)4055-4064
Number of pages10
JournalJournal of Clinical Investigation
Volume120
Issue number11
DOIs
StatePublished - Nov 1 2010
Externally publishedYes

Fingerprint

Mitochondrial Genome
Mitochondrial DNA
Doxorubicin
Maintenance
Mutation
Wounds and Injuries
Modifier Genes
Gene Components
Kidney
Podocytes
Inbred Strains Mice
Double-Stranded DNA Breaks
Mitochondrial Proteins
DNA Damage
Cell Survival
Mitochondria
Proteins
Chromosomes
Phenotype

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Papeta, N., Zheng, Z., Schon, E. A., Brosel, S., Altintas, M. M., Nasr, S. H., ... Gharavi, A. G. (2010). Prkdc participates in mitochondrial genome maintenance and prevents adriamycin-induced nephropathy in mice. Journal of Clinical Investigation, 120(11), 4055-4064. https://doi.org/10.1172/JCI43721

Prkdc participates in mitochondrial genome maintenance and prevents adriamycin-induced nephropathy in mice. / Papeta, Natalia; Zheng, Zongyu; Schon, Eric A.; Brosel, Sonja; Altintas, Mehmet M.; Nasr, Samih H.; Reiser, Jochen; D'Agati, Vivette D.; Gharavi, Ali G.

In: Journal of Clinical Investigation, Vol. 120, No. 11, 01.11.2010, p. 4055-4064.

Research output: Contribution to journalArticle

Papeta, N, Zheng, Z, Schon, EA, Brosel, S, Altintas, MM, Nasr, SH, Reiser, J, D'Agati, VD & Gharavi, AG 2010, 'Prkdc participates in mitochondrial genome maintenance and prevents adriamycin-induced nephropathy in mice', Journal of Clinical Investigation, vol. 120, no. 11, pp. 4055-4064. https://doi.org/10.1172/JCI43721
Papeta, Natalia ; Zheng, Zongyu ; Schon, Eric A. ; Brosel, Sonja ; Altintas, Mehmet M. ; Nasr, Samih H. ; Reiser, Jochen ; D'Agati, Vivette D. ; Gharavi, Ali G. / Prkdc participates in mitochondrial genome maintenance and prevents adriamycin-induced nephropathy in mice. In: Journal of Clinical Investigation. 2010 ; Vol. 120, No. 11. pp. 4055-4064.
@article{08b2949076fb4b3ca65f877a467897e2,
title = "Prkdc participates in mitochondrial genome maintenance and prevents adriamycin-induced nephropathy in mice",
abstract = "Adriamycin (ADR) is a commonly used chemotherapeutic agent that also produces significant tissue damage. Mutations to mitochondrial DNA (mtDNA) and reductions in mtDNA copy number have been identified as contributors to ADR-induced injury. ADR nephropathy only occurs among specific mouse inbred strains, and this selective susceptibility to kidney injury maps as a recessive trait to chromosome 16A1-B1. Here, we found that sensitivity to ADR nephropathy in mice was produced by a mutation in the Prkdc gene, which encodes a critical nuclear DNA double-stranded break repair protein. This finding was confirmed in mice with independent Prkdc mutations. Overexpression of Prkdc in cultured mouse podocytes significantly improved cell survival after ADR treatment. While Prkdc protein was not detected in mitochondria, mice with Prkdc mutations showed marked mtDNA depletion in renal tissue upon ADR treatment. To determine whether Prkdc participates in mtDNA regulation, we tested its genetic interaction with Mpv17, which encodes a mitochondrial protein mutated in human mtDNA depletion syndromes (MDDSs). While single mutant mice were asymptomatic, Prkdc/Mpv17 double-mutant mice developed mtDNA depletion and recapitulated many MDDS and ADR injury phenotypes. These findings implicate mtDNA damage in the development of ADR toxicity and identify Prkdc as a MDDS modifier gene and a component of the mitochondrial genome maintenance pathway.",
author = "Natalia Papeta and Zongyu Zheng and Schon, {Eric A.} and Sonja Brosel and Altintas, {Mehmet M.} and Nasr, {Samih H.} and Jochen Reiser and D'Agati, {Vivette D.} and Gharavi, {Ali G.}",
year = "2010",
month = "11",
day = "1",
doi = "10.1172/JCI43721",
language = "English (US)",
volume = "120",
pages = "4055--4064",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "11",

}

TY - JOUR

T1 - Prkdc participates in mitochondrial genome maintenance and prevents adriamycin-induced nephropathy in mice

AU - Papeta, Natalia

AU - Zheng, Zongyu

AU - Schon, Eric A.

AU - Brosel, Sonja

AU - Altintas, Mehmet M.

AU - Nasr, Samih H.

AU - Reiser, Jochen

AU - D'Agati, Vivette D.

AU - Gharavi, Ali G.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Adriamycin (ADR) is a commonly used chemotherapeutic agent that also produces significant tissue damage. Mutations to mitochondrial DNA (mtDNA) and reductions in mtDNA copy number have been identified as contributors to ADR-induced injury. ADR nephropathy only occurs among specific mouse inbred strains, and this selective susceptibility to kidney injury maps as a recessive trait to chromosome 16A1-B1. Here, we found that sensitivity to ADR nephropathy in mice was produced by a mutation in the Prkdc gene, which encodes a critical nuclear DNA double-stranded break repair protein. This finding was confirmed in mice with independent Prkdc mutations. Overexpression of Prkdc in cultured mouse podocytes significantly improved cell survival after ADR treatment. While Prkdc protein was not detected in mitochondria, mice with Prkdc mutations showed marked mtDNA depletion in renal tissue upon ADR treatment. To determine whether Prkdc participates in mtDNA regulation, we tested its genetic interaction with Mpv17, which encodes a mitochondrial protein mutated in human mtDNA depletion syndromes (MDDSs). While single mutant mice were asymptomatic, Prkdc/Mpv17 double-mutant mice developed mtDNA depletion and recapitulated many MDDS and ADR injury phenotypes. These findings implicate mtDNA damage in the development of ADR toxicity and identify Prkdc as a MDDS modifier gene and a component of the mitochondrial genome maintenance pathway.

AB - Adriamycin (ADR) is a commonly used chemotherapeutic agent that also produces significant tissue damage. Mutations to mitochondrial DNA (mtDNA) and reductions in mtDNA copy number have been identified as contributors to ADR-induced injury. ADR nephropathy only occurs among specific mouse inbred strains, and this selective susceptibility to kidney injury maps as a recessive trait to chromosome 16A1-B1. Here, we found that sensitivity to ADR nephropathy in mice was produced by a mutation in the Prkdc gene, which encodes a critical nuclear DNA double-stranded break repair protein. This finding was confirmed in mice with independent Prkdc mutations. Overexpression of Prkdc in cultured mouse podocytes significantly improved cell survival after ADR treatment. While Prkdc protein was not detected in mitochondria, mice with Prkdc mutations showed marked mtDNA depletion in renal tissue upon ADR treatment. To determine whether Prkdc participates in mtDNA regulation, we tested its genetic interaction with Mpv17, which encodes a mitochondrial protein mutated in human mtDNA depletion syndromes (MDDSs). While single mutant mice were asymptomatic, Prkdc/Mpv17 double-mutant mice developed mtDNA depletion and recapitulated many MDDS and ADR injury phenotypes. These findings implicate mtDNA damage in the development of ADR toxicity and identify Prkdc as a MDDS modifier gene and a component of the mitochondrial genome maintenance pathway.

UR - http://www.scopus.com/inward/record.url?scp=78049418710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049418710&partnerID=8YFLogxK

U2 - 10.1172/JCI43721

DO - 10.1172/JCI43721

M3 - Article

C2 - 20978358

AN - SCOPUS:78049418710

VL - 120

SP - 4055

EP - 4064

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 11

ER -